Neos Therapeutics, LP
FDA inspection history in Grand Prairie, Texas, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at Grand Prairie, Texas.
Cited most
Across all Neos Therapeutics observations on file
- 21 CFR 211.160General requirements1
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures1
The complete Neos Therapeutics file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Grand Prairie, Texas
One Form 483 · 2023 · 2 observations
Latest: Form 483, Aug 25, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-08-25 | 483 Form 483 | Grand Prairie, Texas | 2 | $99 |
FEI number 3000205839 · most recent document Aug 25, 2023
About Neos Therapeutics, LP
How many FDA Form 483s has Neos Therapeutics, LP received?
FDA Intel has 1 Form 483 on file for Neos Therapeutics, LP; the most recent is dated Aug 25, 2023.
When was Neos Therapeutics, LP last inspected by FDA?
The most recent FDA inspection document on file for Neos Therapeutics, LP is a Form 483 dated Aug 25, 2023, for the site in Grand Prairie, Texas.
What did FDA cite at Neos Therapeutics, LP?
The regulations cited most in the observations on file for Neos Therapeutics, LP are 21 CFR 211.160 (General requirements), 1 time; 21 CFR 211.84 (Testing and approval or rejection of components, drug product containers, and closures), 1 time.